Lars Holger Ehlers (Lars H Ehlers)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Multiple Myeloma

Borderline Personality Disorder

Top Venues

PharmacoEconomics - open

Journal of medical Internet research

This page only lists publications with an associated author ORCID identifier.

Publications

Matilde Slot, Thomas Bøjer Rasmussen, Mette Nørgaard, Carsten Schade Larsen, Lars Holger Ehlers
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study. PharmacoEconomics - open (2024)
E P Jørgensen, D V Muttuvelu, Tunde Peto, S Natarajan, J Davies, Pearse Andrew Keane, Lars Holger Ehlers
Implementing teleophthalmology services to improve cost-effectiveness of the national eye care system. Eye (London, England) (2024)
Kristian D Lyng, Chris Djurtoft, Malene K Bruun, Mads N Christensen, Rikke E Lauritsen, Jesper B Larsen, Kathryn A Birnie, Jennifer Nan Stinson, Morten S Hoegh, Thorvaldur Skuli Palsson, Anne Estrup Olesen, Lars Arendt-Nielsen, Lars Holger Ehlers, Kirsten Fonager, Martin B Jensen, Hanne Würtzen, Patricia A Poulin, Gitte Handberg, Connie Ziegler, Lars B Moeller, Judi Olsen, Lotte Heise, Michael Skovdal Rathleff
What is known and what is still unknown within chronic musculoskeletal pain? A systematic evidence and gap map. Pain (2023)
Matilde Slot, Carsten Utoft Niemann, Lars Holger Ehlers, Emelie Curovic Rotbain
Cost-effectiveness of targeted treatment vs chemoimmunotherapy in treatment-naïve unfit CLL without TP53 aberrations. Blood advances (2023)
Jorge Jacob, Tor Biering-Sørensen, Lars Holger Ehlers, Christina H Edwards, Kristin Greve-Isdahl Mohn, Anna Nilsson, Jonas Hjelmgren, Wenkang Ma, Yuvraj Sharma, Emanuele Ciglia, Joaquin F Mould-Quevedo
Cost-Effectiveness of Vaccination of Older Adults with an MF59 ® -Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden. Vaccines 11 (4) (2023)
Henrik Vitus Bering Laursen, Emmelie Ploug Jørgensen, Peter Vestergaard, Lars Holger Ehlers
A Systematic Review of Cost-Effectiveness Studies of Newer Non-Insulin Antidiabetic Drugs: Trends in Decision-Analytical Models for Modelling of Type 2 Diabetes Mellitus. PharmacoEconomics (2023)
Jorge Jacob, Tor Biering-Sørensen, Lars Holger Ehlers, Christina H Edwards, Kristin Greve-Isdahl Mohn, Anna Nilsson, Jonas Hjelmgren, Wenkang Ma, Yuvraj Sharma, Emanuele Ciglia, Joaquin F Mould-Quevedo
Cost-Effectiveness of Vaccination of Older Adults with an MF59 ® -Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden. Vaccines 11 (4) (2023)
Jorge Jacob, Tor Biering-Sørensen, Lars Holger Ehlers, Christina H Edwards, Kristin Greve-Isdahl Mohn, Anna Nilsson, Jonas Hjelmgren, Wenkang Ma, Yuvraj Sharma, Emanuele Ciglia, Joaquin F Mould-Quevedo
Cost-Effectiveness of Vaccination of Older Adults with an MF59 ® -Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden. Vaccines 11 (4) (2023)
Jorge Jacob, Tor Biering-Sørensen, Lars Holger Ehlers, Christina H Edwards, Kristin Greve-Isdahl Mohn, Anna Nilsson, Jonas Hjelmgren, Wenkang Ma, Yuvraj Sharma, Emanuele Ciglia, Joaquin F Mould-Quevedo
Cost-Effectiveness of Vaccination of Older Adults with an MF59 ® -Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden. Vaccines 11 (4) (2023)
Kim Mathiasen, Tonny Elmose Andersen, Mia Beck Lichtenstein, Lars Holger Ehlers, Heleen Riper, Annet Kleiboer, Kirsten Kaya Roessler
The Clinical Effectiveness of Blended Cognitive Behavioral Therapy Compared With Face-to-Face Cognitive Behavioral Therapy for Adult Depression: Randomized Controlled Noninferiority Trial. Journal of medical Internet research 24 (9) (2022)
Lars Børty, Rasmus Froberg Brøndum, Heidi S Christensen, Charles Vestereghem, Marianne Tang Severinsen, Søren Paaske Johnsen, Lars Holger Ehlers, Ursula Falkmer, Laurids Østergaard Poulsen, Martin Bøgsted
Trends and drivers of pharmaceutical expenditures from systemic anti-cancer therapy. The European journal of health economics : HEPAC : health economics in prevention and care (2022)
Lars Holger Ehlers, Flemming Axelsen, Thomas Bøjer Rasmussen, Jens Dollerup, Nils Abild Jespersen, Carsten Schade Larsen, Mette Nørgaard
Cost of non-communicable diseases in people living with HIV in the Central Denmark Region. HIV medicine (2022)
Sabine Michelsen Raunbak, Anne Sig Sørensen, Louise Hansen, Flemming Skjøth, Torben Bjerregaard Larsen, Lars Holger Ehlers
Cost Effectiveness of Patient Self-Managed Warfarin Compared with Direct Oral Anticoagulants in Atrial Fibrillation: An Economic Evaluation in a Danish Healthcare Sector Setting. PharmacoEconomics - open 6 (4) (2022)
Lars Holger Ehlers, Morten B Jensen, Henrik Schack
Competitive tenders on analogue hospital pharmaceuticals in Denmark 2017-2020. Journal of pharmaceutical policy and practice 15 (1) (2022)
Sidsel Lund Laursen, Stig Helweg-Joergensen, Astrid Langergaard, Jesper Søndergaard, Sabrina Storgaard Sørensen, Kim Mathiasen, Mia Beck Lichtenstein, Lars Holger Ehlers
Mobile Diary App Versus Paper-Based Diary Cards for Patients With Borderline Personality Disorder: Economic Evaluation. Journal of medical Internet research 23 (11) (2021)
Rasmus Froberg Brøndum, Anne Sig Sørensen, Lars Børty, Charles Vestereghem, Anne S Rytter, Marlene M Nielsen, Marianne Tang Severinsen, Paw Jensen, Henrik Gregersen, Tarec Christoffer El-Galaly, Karen Dybkær, Lars Holger Ehlers, Martin Bøgsted, Anne Stidsholt Roug
Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system. Future oncology (London, England) 17 (25) (2021)